193 related articles for article (PubMed ID: 37071163)
21. Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.
Petersen J; Lindner C; Hakki M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1648-1653. PubMed ID: 31002988
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation.
Ohwada S; Iida T; Hirayama D; Sudo G; Kubo T; Nojima M; Yamashita K; Yamano H; Nakase H
PLoS One; 2018; 13(7):e0200627. PubMed ID: 30059537
[TBL] [Abstract][Full Text] [Related]
23. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic disagreement between clinical standard histopathological- and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children.
Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Mattsson J; Gustafsson B; Casswall TH
Pediatr Transplant; 2020 Dec; 24(8):e13824. PubMed ID: 33085820
[TBL] [Abstract][Full Text] [Related]
25. Sensitivities of Biopsy Sites in the Endoscopic Evaluation of Graft-Versus-Host Disease: Retrospective Review from a Tertiary Center.
Ip S; Marquez V; Schaeffer DF; Donnellan F
Dig Dis Sci; 2016 Aug; 61(8):2351-2356. PubMed ID: 27025373
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2.
Zeiser R; Chen YB; Youssef NN; Ayuk F
Br J Haematol; 2023 May; 201(4):620-627. PubMed ID: 36965050
[TBL] [Abstract][Full Text] [Related]
27. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of gastrointestinal symptoms in pediatric patients post hematopoietic stem cell transplantation: Ileo-colonoscopy versus sigmoidoscopy. A single-center experience and review of literature.
Slae M; Pinhasov D; Averbuch D; Davidovics Z; Or EE; Reif S; Stepensky P; Zaidman I
Pediatr Blood Cancer; 2021 Nov; 68(11):e29235. PubMed ID: 34264544
[TBL] [Abstract][Full Text] [Related]
29. Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease.
Isshiki K; Kamiya T; Endo A; Okamoto K; Osumi T; Kawai T; Arai K; Tomizawa D; Ohtsuka K; Nagahori M; Imai K; Kato M; Kanegane H
Int J Hematol; 2022 Apr; 115(4):590-594. PubMed ID: 34724153
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using
Cherk MH; Khor R; Barber TW; Yap KSK; Patil S; Walker P; Avery S; Roberts S; Kemp W; Pham A; Bailey M; Kalff V
J Nucl Med; 2022 Dec; 63(12):1899-1905. PubMed ID: 35450959
[TBL] [Abstract][Full Text] [Related]
31. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.
Kreisel W; Dahlberg M; Bertz H; Harder J; Potthoff K; Deibert P; Schmitt-Graeff A; Finke J
Bone Marrow Transplant; 2012 Mar; 47(3):430-8. PubMed ID: 21706064
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic prediction of gastrointestinal graft-versus-host disease based on a clinical- CT- signs nomogram model.
Feng Q; Xu F; Guan K; Li T; Sheng J; Zhong W; Wu H; Li B; Peng P
Insights Imaging; 2024 Mar; 15(1):84. PubMed ID: 38517664
[TBL] [Abstract][Full Text] [Related]
34. Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host Disease.
Khodr J; Zerbib P; Rogosnitzky M; Magro L; Truant S; Yakoub-Agha I; Duhamel A; Seguy D
Ann Surg; 2021 Nov; 274(5):773-779. PubMed ID: 34342300
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of acute graft-versus-host disease.
Aslanian H; Chander B; Robert M; Cooper D; Proctor D; Seropian S; Jain D
Dig Dis Sci; 2012 Mar; 57(3):720-5. PubMed ID: 22011927
[TBL] [Abstract][Full Text] [Related]
36. PET assessment of acute gastrointestinal graft versus host disease.
Scott AP; Henden A; Kennedy GA; Tey SK
Bone Marrow Transplant; 2023 Sep; 58(9):973-979. PubMed ID: 37537245
[TBL] [Abstract][Full Text] [Related]
37. Choice of Endoscopic Procedure in Children With Clinically Suspected Gastrointestinal Graft-versus-host Disease.
Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Casswall TH; Gustafsson B
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):744-750. PubMed ID: 29045348
[TBL] [Abstract][Full Text] [Related]
38. CT features with pathologic correlation of acute gastrointestinal graft-versus-host disease after bone marrow transplantation in adults.
Kalantari BN; Mortelé KJ; Cantisani V; Ondategui S; Glickman JN; Gogate A; Ros PR; Silverman SG
AJR Am J Roentgenol; 2003 Dec; 181(6):1621-5. PubMed ID: 14627585
[TBL] [Abstract][Full Text] [Related]
39. Bowel wall thickness is a strong predictor of steroid-refractory acute graft-versus-host disease with gut involvement after allo-HSCT.
Drokov M; Yatsyk G; Kireeva A; Pirikova O; Dubnyak D; Kuzmina L; Vasilyeva V; Popova N; Starikova O; Parovichnikova E; Savchenko V
Int J Hematol; 2022 Apr; 115(4):545-552. PubMed ID: 35098481
[TBL] [Abstract][Full Text] [Related]
40. Cellular senescence marker p16
Kuba A; Raida L; Brychtova S; Flodr P; Mrazek F; Kriegova E; Faber E; Papajik T
Transpl Immunol; 2023 Feb; 76():101768. PubMed ID: 36470572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
